Wedmont Private Capital Grows Holdings in The Cooper Companies, Inc. (NASDAQ:COO)

Wedmont Private Capital boosted its position in shares of The Cooper Companies, Inc. (NASDAQ:COO) by 6.9% during the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 3,774 shares of the medical device company’s stock after acquiring an additional 243 shares during the period. Wedmont Private Capital’s holdings in Cooper Companies were worth $343,000 at the end of the most recent quarter.

Other large investors have also added to or reduced their stakes in the company. Vanguard Group Inc. lifted its holdings in Cooper Companies by 303.0% in the 1st quarter. Vanguard Group Inc. now owns 23,099,975 shares of the medical device company’s stock worth $2,343,723,000 after purchasing an additional 17,367,502 shares in the last quarter. Capital World Investors boosted its position in shares of Cooper Companies by 301.7% during the first quarter. Capital World Investors now owns 5,654,023 shares of the medical device company’s stock worth $573,657,000 after acquiring an additional 4,246,519 shares during the last quarter. Janus Henderson Group PLC grew its stake in Cooper Companies by 279.8% during the first quarter. Janus Henderson Group PLC now owns 3,437,064 shares of the medical device company’s stock valued at $348,723,000 after acquiring an additional 2,532,186 shares in the last quarter. Bessemer Group Inc. grew its stake in Cooper Companies by 305.2% during the first quarter. Bessemer Group Inc. now owns 2,000,910 shares of the medical device company’s stock valued at $203,013,000 after acquiring an additional 1,507,049 shares in the last quarter. Finally, Swedbank AB bought a new stake in Cooper Companies in the 1st quarter valued at $139,246,000. Hedge funds and other institutional investors own 24.39% of the company’s stock.

Analyst Upgrades and Downgrades

COO has been the topic of several research reports. Needham & Company LLC reaffirmed a “hold” rating on shares of Cooper Companies in a report on Friday, May 31st. Piper Sandler reaffirmed an “overweight” rating and set a $115.00 price objective on shares of Cooper Companies in a report on Wednesday, July 3rd. Jefferies Financial Group upgraded shares of Cooper Companies from a “hold” rating to a “buy” rating and boosted their price target for the stock from $107.00 to $115.00 in a research report on Tuesday, July 16th. Finally, Robert W. Baird increased their price objective on shares of Cooper Companies from $116.00 to $118.00 and gave the company an “outperform” rating in a research report on Friday, May 31st. Four analysts have rated the stock with a hold rating and nine have assigned a buy rating to the company. According to data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $111.78.

Cooper Companies Trading Up 1.1 %

COO stock traded up $1.02 during midday trading on Tuesday, reaching $91.99. The company’s stock had a trading volume of 1,032,298 shares, compared to its average volume of 1,111,885. The Cooper Companies, Inc. has a 1 year low of $75.93 and a 1 year high of $104.07. The firm has a market capitalization of $18.32 billion, a price-to-earnings ratio of 53.95, a PEG ratio of 2.34 and a beta of 0.98. The stock has a fifty day simple moving average of $90.95 and a two-hundred day simple moving average of $94.03. The company has a debt-to-equity ratio of 0.34, a quick ratio of 1.14 and a current ratio of 1.95.

Cooper Companies (NASDAQ:COO) last issued its earnings results on Thursday, May 30th. The medical device company reported $0.85 EPS for the quarter, topping analysts’ consensus estimates of $0.83 by $0.02. The business had revenue of $942.60 million for the quarter, compared to the consensus estimate of $948.07 million. Cooper Companies had a net margin of 9.11% and a return on equity of 8.87%. The company’s revenue for the quarter was up 7.4% compared to the same quarter last year. During the same period in the prior year, the firm earned $0.77 EPS. On average, equities research analysts predict that The Cooper Companies, Inc. will post 3.57 EPS for the current year.

Cooper Companies Profile

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.